Walleye Capital’s Medifast MED Stock Holding History

Walleye Capital’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10	Buy	+1	New	+$11	﹤0.01%	4312
2025 Q4	–	Sell	-29,940	Closed	-$409K	–	4905
2025 Q3	$409K	Sell	29,940 -8,154	-21%	-$114K	﹤0.01%	2784
2025 Q2	$535K	Buy	38,094 +25,473	+202%	+$335K	﹤0.01%	2590
2025 Q1	$170K	Buy	+12,621	New	+$190K	﹤0.01%	3380
2024 Q4	–	Sell	-6,457	Closed	-$124K	–	5259
2024 Q3	$124K	Sell	6,457 -5,017	-44%	-$96.7K	﹤0.01%	4300
2024 Q2	$250K	Sell	11,474 -25,176	-69%	-$671K	﹤0.01%	4131
2024 Q1	$1.4M	Buy	+36,650	New	+$1.78M	﹤0.01%	2263
2023 Q4	–	Sell	-3,377	Closed	-$253K	–	5287
2023 Q3	$253K	Sell	3,377 -5,724	-63%	-$508K	﹤0.01%	3378
2023 Q2	$839K	Buy	+9,101	New	+$810K	﹤0.01%	2000
2023 Q1	–	Sell	-1,071	Closed	-$119K	–	4201
2022 Q4	$124K	Sell	1,071 -19,234	-95%	-$2.24M	﹤0.01%	2287
2022 Q3	$2.2M	Buy	+20,305	New	+$2.91M	0.04%	506
2021 Q2	–	Sell	-1,482	Closed	-$314	–	1447
2021 Q1	$314	Buy	+1,482	New	+$355K	0.02%	735
2020 Q4	–	Sell	-1,458	Closed	-$240K	–	1035
2020 Q3	$240K	Buy	+1,458	New	+$240K	0.03%	561
2019 Q3	–	Sell	-240	Closed	-$31K	–	2108
2019 Q2	$31K	Buy	+240	New	+$33.3K	﹤0.01%	1465

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Walleye Capital's MED Position: Q1 2026 in Review

Walleye Capital opened a new position in Medifast (MED) in Q1 2026: 1 share worth $10. The stake represents ﹤0.01% of the portfolio and ranks #4312 among its holdings. This is a return to the name: Walleye Capital previously reported a position in MED as recently as Q3 2025.

Walleye Capital first reported a position in MED in Q2 2019 and has held it in 14 quarters since. The position peaked at $2.2M in Q3 2022. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

Walleye Capital held 1 share of Medifast worth $10 as of Q1 2026.
Medifast was a new Walleye Capital position in Q1 2026.
Medifast made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #4312 holding.
Walleye Capital first reported a position in Medifast in Q2 2019 and has held it in 14 quarters since.
Walleye Capital's Medifast position peaked at $2.2M in Q3 2022.
111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.